M&A - LUMOS PHARMA, INC.

Form Type: SCHEDULE 13G/A

Filing Date: 2025-02-13

Corporate Action: Acquisition

Type: Update

Accession Number: 000108514625001315

Filing Summary: This Schedule 13G/A filing reports an update on the ownership of common stock in Lumos Pharma, Inc. The report indicates that Private Advisor Group, LLC, acting in its capacity as an investment adviser, had previously managed shares owned by clients. These clients granted discretionary authority to dispose of or direct the disposition of the shares to an independent contractor of Private Advisor Group. Notably, as a result of a recent acquisition by Double Point, the common shares initially reported are no longer held by these clients. The filing also clarifies that none of the clients were known to have more than five percent of the common shares, and emphasizes that the securities were acquired in the ordinary course of business and not intended for influencing control over Lumos Pharma, Inc.

Document Link: View Document